Reference : Analytical strategies for the detection of counterfeit erectile dysfunction drugs.
Parts of books : Contribution to collective works
Human health sciences : Pharmacy, pharmacology & toxicology
http://hdl.handle.net/2268/129935
Analytical strategies for the detection of counterfeit erectile dysfunction drugs.
English
Sacre, Pierre-Yves mailto [Université de Liège - ULg > Département de pharmacie > Chimie analytique >]
Deconinck, Eric []
De Beer, Jacques []
In press
Counterfeit Medicines Volume II: Detection, Identification and Analysis
Wang, Perry
Wertheimer, Albert
ILM Publications
Yes
9781906799182
St Albans
United Kingdom
[en] Counterfeit medicines ; PDE-5 inhibitors ; Chemometrics
[en] Among all classes of drugs, the type 5 phosphodiesterase inhibitors (PDE5-i) (sildenafil, vardenafil and tadalafil) are the most counterfeited and copied in industrialized countries. This is why it is very important for regulatory agencies to have a panel of analytical methods to analyse these drugs and to be able to detect counterfeit or substandard medicines.
During this chapter, several analytical techniques will be described and discussed. Among spectroscopic techniques, Raman, NIR, FT-IR and chemical imaging techniques will be envisaged. Their ability to detect counterfeits and predict if a new sample is genuine or not will be presented. Other techniques such as XRay powder diffraction and NMR spectroscopies will be briefly presented.
Chromatographic impurity fingerprints will be considered and described for the analysis of suspect samples of Cialis® and Viagra®. Once again, the possibility to predict the authenticity of a new sample by the mean of this technique is envisaged.
Finally, a MS-compatible UHPLC-UV method for the analysis of the three authorised PDE5-i and some of their analogues will be shortly described. This technique has been validated using spiked placebo samples in a vegetal matrix representing a suspect sample with a complex matrix.
As a conclusion, a generic strategy for the detection and quality evaluation of counterfeit drugs will be presented.
Researchers ; Professionals
http://hdl.handle.net/2268/129935

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
SACRE PY chapter mis en page.pdfAuthor postprint264.51 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.